ANG1005 in Leptomeningeal Disease From Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Leptomeningeal Carcinomatosis|Leptomeningeal Metastases|Brain Metastases|HER2-negative Breast Cancer
Interventions: DRUG: ANG1005|DRUG: Physician's Best Choice
Sponsor: Angiochem Inc